Probiotic pill aims to stop recurrent cystitis without antibiotics
NCT ID NCT07676604
First seen Jun 30, 2026 · Last updated Jul 07, 2026 · Updated 4 times
Summary
This study tests whether a daily probiotic supplement called Colipral® can prevent repeat bladder infections (cystitis) in menopausal women aged 55–70. Participants take either the probiotic or a placebo for 12 weeks and are monitored for 24 weeks to see if they have fewer infections, need fewer antibiotics, and feel better overall. The goal is to find a safe, non-antibiotic way to manage this common condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Colipral® (probiotic strain Escherichia coli 5C (ECP24®))
- What this could lead to
- If effective, this probiotic could offer a non-antibiotic way to prevent recurrent cystitis in menopausal women, reducing antibiotic use and improving quality of life.
- What could go wrong
- This is a small, early-stage trial with 134 participants. The probiotic may not prove better than placebo, and individual results may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT CYSTITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.